DE LERMA BARBARO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 5.090
EU - Europa 4.885
AS - Asia 1.099
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
OC - Oceania 2
Totale 11.119
Nazione #
US - Stati Uniti d'America 4.981
IT - Italia 2.503
UA - Ucraina 955
TR - Turchia 375
SE - Svezia 366
VN - Vietnam 328
FI - Finlandia 252
CN - Cina 234
DE - Germania 232
IE - Irlanda 204
RU - Federazione Russa 120
SG - Singapore 119
CA - Canada 107
GB - Regno Unito 103
FR - Francia 100
BR - Brasile 31
IN - India 24
BE - Belgio 12
JP - Giappone 12
NL - Olanda 11
CZ - Repubblica Ceca 7
CH - Svizzera 6
EU - Europa 5
RS - Serbia 4
AT - Austria 3
ES - Italia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GL - Groenlandia 1
GR - Grecia 1
HK - Hong Kong 1
KE - Kenya 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PS - Palestinian Territory 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 11.119
Città #
Milan 1.837
Jacksonville 723
Chandler 529
Fairfield 453
Woodbridge 354
Ashburn 324
Wilmington 257
Princeton 245
Ann Arbor 229
Izmir 229
Nyköping 216
Dublin 204
Dearborn 194
Seattle 189
Houston 167
Dong Ket 155
Boardman 147
Cambridge 134
Rome 125
Singapore 109
Como 103
Toronto 96
Beijing 92
San Mateo 92
New York 58
San Diego 55
Dallas 44
Ogden 38
Chicago 33
Düsseldorf 29
Verona 23
Pune 22
Hefei 20
Los Angeles 19
Helsinki 18
Nanjing 15
Santa Clara 15
London 14
Brussels 12
Guangzhou 11
Kunming 10
Tokyo 10
Norwalk 9
Jinan 8
Munich 8
Redwood City 8
Ponte Lambro 7
Washington 7
Auburn Hills 6
Rozzano 6
Villanova D'asti 6
Falls Church 5
Frankfurt am Main 5
Fuzhou 5
Vanzaghello 5
Zhengzhou 5
Belgrade 4
Casorezzo 4
Changsha 4
Hebei 4
Hounslow 4
Ottawa 4
Seveso 4
São Paulo 4
Varese 4
Voghera 4
Xian 4
Amsterdam 3
Chiswick 3
Chongqing 3
Costa Mesa 3
Edinburgh 3
Huzhou 3
Indiana 3
Nanchang 3
Olomouc 3
Phoenix 3
San Francisco 3
Shenyang 3
Wenzhou 3
Wuhan 3
Zurich 3
Brno 2
Chengdu 2
Coimbatore 2
Gavirate 2
Graz 2
Legnano 2
Montreal 2
Monza 2
Muggiò 2
Prague 2
Prescot 2
Quzhou 2
Redmond 2
Rudolfstetten 2
Sesto San Giovanni 2
Shanghai 2
Simi Valley 2
Wandsworth 2
Totale 7.864
Nome #
Surface protein components from entomopathogenic nematodes and their symbiotic bacteria: effects on immune responses of the greater wax moth, Galleria mellonella (Lepidoptera: Pyralidae) 171
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy 164
Divergent evolution in the mechanisms controlling major histocompatibility complex class II gene transcription in mouse and human 160
The MHC class II transactivator: prey and hunter in infectious diseases 158
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells 154
New strategies of mammary cancer vaccination 152
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory. 146
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. 136
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication 136
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory 136
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review) 134
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions. 133
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis 131
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle 130
In Vivo Effects of A Pro-PO System Inhibitor on the Phagocytosis of Xenorhabdus Nematophila in Galleria Mellonella Larvae 128
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory 127
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 126
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR 125
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines 116
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions 115
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy 113
Therapy-induced antitumor vaccination by targeting tumor necrosis factor  to tumor vessels in combination with melphalan 111
MHC immunoevasins: protecting the pathogen reservoir in infection 110
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis 110
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation 109
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y 109
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA 108
Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules 107
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells. 107
Physiologic target of the Air-1 trans-activator revealed by stable transfection assay 107
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis 106
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions 105
The complex liaison between cachexia and tumor burden 105
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory. 102
Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells 102
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan 97
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells 95
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication 95
Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and partecipatine in the development of anti-inflammatory functional behavior of phagocytic macrophages 94
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules 94
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA 94
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA 93
Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class-II molecules combined with naked DNA interleukin-12 gene transfer 93
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy. 92
Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy. 91
Analysis of microchimerism in thyroid autoimmune diseases 91
The utility of introducing a measurement of tumor burden for a better assessment of cancer cachexia. 91
CIITA reduced transcription as the cause of HLA class II downregulation in human macrophages during bacterial phagocytosis 90
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1 90
Irradiated CIITA-positive mammary adenocarcinoma cells act as potent anti-tumor preventive vaccine by inducine tumor-specific CD4+ T cell priming and CD8+ T cell effector functions 90
Regulation of HLA antigen expression in HIV infected cells 90
Espressione delle molecole HLA di classe II in cellule di epatocarcinoma classe II negative dopo trasfezione del transattivatore CIITA. Acquisizione della capacità di processare e presentare l'antigene 89
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy. 88
Regolazione dell'espressione dei geni del Complesso Maggiore di Istocompatibilità HLA e di CD4 in cellule infettate da HIV: effetto di TAT 88
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis 88
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan 87
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down-modulation in normal human macrophages during bacterial phagocytosis 87
Higly stable oligomerization forms of HIV-1 Tat detected by Monoclonal antibodies and requirement of monomeric forms for the transactivating function of the HIV-1 LTR 86
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections 86
La presentazione antigenica su molecole di II classe HLA è profondamente alterata in seguito a fagocitosi batterica 85
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity. 85
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication 85
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication 85
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA) 85
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA 85
The AIR-1 locus encoded HLA class II transcriptional activator (CIITA) inhibits HIV-1 replication by blocking the function of HIV-1 Tat 84
The complex liaison between vulnerability to cachexia and tumor burden. 84
Regulation of HLA antigen expression in phagocytes with mycobacteria 83
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection. 83
Imaging guided percutaneous microwave ablation of tumors. 81
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication 81
HTLV2 influence on pathways regulating proliferation and death in B cell line BJAB 81
Methylation of CIITA promoter IV causes loss of HLA-II inducibility by gamma-IFN in promyelocytic cells 80
The MHC class II transactivator is a strong physiologic antagonist of HIV-1 replication 79
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down modulation in normal human macrophages during bacterial phagocytosis. 79
Induction of tumor regression by gene transfer of the MHC class II transactivator CIITA 78
Control of tumor growth in vivo by gene therapy with the MHC class II transactivator (CIITA) 78
Irradiated CIITA-positive mammary adenocarcinoma cells act as effective tumor cell vaccine inducing both tumor-specific CD4+ and CD8+ T immune responses and tumor rejection upon challenge. 77
HLA-DQ expression is differently regulated from -DR and -DP 77
The replication of HTLV-2 and the expression of HLA class II transcriptional activator (CIITA) are inversely correlated 77
The molecular and cellular basis of tumor rejection after vaccination with mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA 77
Regulation of HLA antigen expression in phagocytes treated with mycobacteria 76
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA il regolatore trascrizionale dell'espressione dell'HLA-II 75
HLA class II-dependent antigen presentation is deeply impaired in macrophage reservoir of infection 73
Tumor vaccination by CIITA-mediated MHC-II-expressing neoplastic cells 73
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA 73
Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA 73
Constitutive and inducible expression of HLA class II genes in normal cells is under the control of the AIR-1-encoded CIITA trans-activator 73
Inhibition of human T cell leukemia virus type 2 (HTLV-2) replication by the suppressive action of class II transactivator and nuclear factor Y 72
The immunological basis of tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. 72
Temporal and quantitative relations between CIITA and HLA class II expression 72
Innate and adaptive immune function of the MHC class II transactivator, CIITA, against human tumor retroviruses HTLV-2 and HTLV-1 72
The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in differentiating myelomonocytic cells. 71
Strong adaptive antitumor immune response elicited by targeting tumor necrosis factor a to tumor vessels in combination with melphalan. 71
Expression of AIR-1/CIITA transactivator in B cell x plasmacytoma somatic cell hybrids restores HLA-DR and -DP expression, but not -DQ 71
La fagocitosi di Mycobacterium Tuberculosis ha effetti opposti sull'espressione di superficie delle molecole HLA di classe I e di classe II 70
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis 70
The AIR-1 locus-encoded HLA class II transcriptional activator (CIITA) inhibits HIV-1 productive infection by blocking the function of HIV-1 Tat 69
Reverse correlation between HTLV-II replication and expression of CIITA, the major regulator of HLA class II transcription 69
Induction of tumor rejection by gene transfer of the MHC class II transactivator CIITA 69
Totale 9.721
Categoria #
all - tutte 44.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020685 0 0 0 0 0 0 0 240 97 184 17 147
2020/20211.447 14 152 8 150 24 161 44 143 264 59 138 290
2021/20221.101 141 133 106 111 22 19 41 95 53 128 91 161
2022/20231.408 151 66 123 167 97 319 0 188 173 37 51 36
2023/20242.818 452 438 505 488 499 220 24 25 104 17 2 44
2024/2025656 13 47 320 32 84 70 79 11 0 0 0 0
Totale 11.167